类风湿关节炎中TNF与IL-6诱导破骨细胞的特征与功能
研究从RA患者和健康供者外周血单核细胞经TNF联合IL-6刺激诱导破骨细胞,证实其具有骨吸收能力、不依赖OPG、经NFATc1及JAK通路分化,且其数量与RA患者mTSS正相关,提示其参与关节破坏。
要点
- TNF联合IL-6可诱导人外周血单核细胞分化为具骨吸收功能的破骨细胞
- 该分化不被OPG抑制,依赖NFATc1并受NFAT及JAK抑制剂阻断
- RA患者中TNF+IL-6诱导破骨细胞数与mTSS正相关
核心结论
- TNF与IL-6诱导的破骨细胞可能参与RA等炎性关节炎的关节破坏病理过程。
研究设计与样本
- 采集RA患者与健康供者外周血,将外周血单核细胞分别与TNF联合IL-6、单用TNF、单用IL-6或RANKL培养,评估骨吸收能力并分析相关分子表达及抑制剂效应。
主要发现
- TNF联合IL-6刺激的外周血单核细胞可分化为能吸收骨基质的破骨细胞,且该分化不被骨保护素(OPG)抑制。
- TNF联合IL-6刺激促进NFATc1表达,NFAT抑制剂和JAK抑制剂均可阻止TNF与IL-6诱导的破骨细胞形成。
- TNF与IL-6诱导的破骨细胞中IL1β、TNF、IL12p40和MMP3表达显著升高,而RANKL诱导的破骨细胞中未见升高。
- RA患者PBMC分化的TNF与IL-6诱导破骨细胞数量与mTSS正相关,而RANKL诱导破骨细胞数量与同一患者全身骨密度(BMD)负相关。
临床怎么用
- 在RA骨破坏评估中可关注TNF与IL-6协同诱导的破骨细胞途径,其不受OPG抑制。
- NFAT抑制剂或JAK抑制剂可能阻断TNF与IL-6诱导的破骨细胞形成。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We have previously reported that stimulation of mouse bone marrow-derived macrophages with tumor necrosis factor (TNF) and interleukin-6 (IL-6) induces differentiation of osteoclast-like cells. We undertook this study to clarify the characterization and function of human TNF and IL-6-induced osteoclasts using peripheral blood collected from patients with rheumatoid arthritis (RA) and healthy donors. METHODS: Peripheral blood monocytes were cultured with a combination of TNF and IL-6, TNF alone, IL-6 alone, or with RANKL, and their bone resorption ability was evaluated. Expression levels of NFATc1, proinflammatory cytokines, and matrix metalloproteinase 3 were analyzed. The effects of NFAT inhibitor and JAK inhibitor were examined. Furthermore, the relationship between the number of TNF and IL-6-induced osteoclasts or RANKL-induced osteoclasts differentiated from peripheral blood mononuclear cells (PBMCs) in patients with RA and the modified total Sharp score (mTSS) or whole-body bone mineral density (BMD) was examined. RESULTS: Peripheral blood monocytes stimulated with a TNF and IL-6-induced osteoclasts were shown to demonstrate the ability to absorb bone matrix. Cell differentiation was not inhibited by the addition of osteoprotegerin. Stimulation with a combination of TNF and IL-6 promoted NFATc1 expression, whereas the NFAT and JAK inhibitors prevented TNF and IL-6-induced osteoclast formation. Expression levels of IL1β, TNF, IL12p40, and MMP3 were significantly increased in TNF and IL-6-induced osteoclasts, but not in RANKL-induced osteoclasts. The number of TNF and IL-6-induced osteoclasts differentiated from PBMCs in patients with RA positively correlated with the mTSS, whereas RANKL-induced osteoclast numbers negatively correlated with the whole-body BMD of the same patients. CONCLUSION: Our results demonstrate that TNF and IL-6-induced osteoclasts may contribute to the pathology of inflammatory arthritis associated with joint destruction, such as RA.
引用
- Yokota K, Sato K, Miyazaki T, et al. Characterization and Function of Tumor Necrosis Factor and Interleukin-6-Induced Osteoclasts in Rheumatoid Arthritis. Arthritis Rheumatol. 2021. PMID: 33512089. doi:10.1002/art.41666
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。